Eisai logo

Eisai

Asia, Tokyo, Japan, Tokyo

Description

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investor Profile

Eisai has backed more than 8 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Japan, Singapore.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Series Unknown (13%)
  • Pre Seed (13%)

Country Focus

  • United States (38%)
  • Japan (25%)
  • Singapore (25%)
  • Finland (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Medical
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Clinical Trials
  • Mobile Apps
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eisai frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
EC
North America, New York, United States, New York
Co-Investments: 1
Ono Venture Investment
North America, California, United States, San Francisco
Co-Investments: 1
EPIC Ventures
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
The Column Group
North America, California, United States, San Francisco
Co-Investments: 1
EM
North America, Colorado, United States, Castle Rock
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does Eisai often collaborate with?

Wendou Niu
Asia, Singapore
Shared Deals: 1
Raman Singh
Asia, Singapore
Shared Deals: 1
KS
North America, Massachusetts, United States, Boston
Shared Deals: 2
MB
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Eisai?

Seed Therapeutics

New York, New York, United States

Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.

BiotechnologyMedicalTherapeutics
Series AAug 6, 2024
Amount Raised: $24,000,000
Casma Therapeutics

Cambridge, Massachusetts, United States

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

BiotechnologyHealth CareTherapeutics
Series CNov 15, 2022
Amount Raised: $46,000,000
Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science
Series ASep 9, 2021
Amount Raised: $10,000,000
Oura

Oulu, Oulu, Finland

Oura is a health technology company that makes and designs wellness wearable rings to track and improve sleep and performance.

Health CareMobile AppsWearables
Series CMay 4, 2021
Amount Raised: $100,000,000
Allm

Tokyo, Tokyo, Japan

Allm is a medical ICT company develops innovative mHealth solutions transforming the way healthcare providers collaborate.

Health CareInformation and Communications Technology (ICT)Information TechnologyMedical
Series AApr 5, 2021
Amount Raised: $50,819,464
Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science
Pre SeedDec 3, 2020
Amount Raised: $2,300,000
Unlearn.AI

San Francisco, California, United States

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Artificial Intelligence (AI)BioinformaticsClinical TrialsLife Science
Series ANov 5, 2020
Amount Raised: $3,000,000
SymBio Pharmaceuticals

Tokyo, Tokyo, Japan

SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series UnknownDec 11, 2009
Amount Raised: $24,704,501